English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Study finds similar ADHD symptom improvement for dexamphetamine and methylphenidate, but weight effects differ
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

SORLA protein may protect the brain from toxic tau tangles
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Federal tax deduction changes linked to local school funding decisions, researchers say
+ Pharmaceuticals
Patient Daily | Jul 17, 2026

Study finds genetic changes in schistosomiasis parasite may signal emerging drug resistance
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Eli Lilly announces $3.8 billion acquisition of AtaiBeckley in psychedelics sector
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Experts discuss emerging alternatives to opioids for pain relief
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Blood-based gene tests may aid early detection of pancreatic cancer, researchers say
+ Pharmaceuticals
Patient Daily | Jul 16, 2026

Medicaroid receives CE marking for hinotori surgical robot system

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation